In this episode, approval of an Ad5 vectored SARS-CoV-2 vaccine for the military in China, description and clinical trials of a Novavax vaccine joining Operation Warp Speed, prevalence of SARS-CoV-2 in Spain, shedding and transmissibility of the virus, and listener email.

Hosts: Vincent Racaniello, Rich Condit, and Kathy Spindler

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

China approves COVID-19 vaccine for military (CNN)
Ad5-vectored COVID-19 vaccine phase I results (Lancet)
US pays $1.6 billion for Novavax vaccine (NY Times)
CEPI awards $388 million to Novavax (Novavax)
HHS on Novavax vaccine (HHS)
Novavax phase I/II trials (GlobeNewswire)
Prevalence of SARS-CoV-2 in Spain (Lancet)
Shedding and transmissibility of SARS-CoV-2 (Nature)
Letters read on TWiV 637
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv

TWiV 637: Clearing the fog of ignorance